- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- BIOCAD Saint Petersburg, Strelna, Russia
Clinical trial condition
Moderate to Severe Plaque Psoriasis
Explore clinical trials studying Moderate to Severe Plaque Psoriasis. Study availability and eligibility vary by location and protocol.
34 public trials
5 recruiting studies
Moderate to Severe Plaque Psoriasis trial results
NCT02607774
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Hot Springs, Arkansas, United States
- Novartis Investigative Site Fair Lawn, New Jersey, United States
NCT01077232
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- Universitaetsklinik Heidelberg /ID# 33810 Heidelberg, Baden-Wurttemberg, Germany
- Universitaetsklinik Heidelberg /ID# 50858 Heidelberg, Baden-Wurttemberg, Germany
- Universitatsklinikum Mannheim /ID# 166130 Mannheim, Baden-Wurttemberg, Germany
- Universitaetsklinikum Erlangen /ID# 34816 Erlangen, Bavaria, Germany
NCT02713295
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- General Univ Hosp "Attikon" /ID# 149517 Athens, Attica, Greece
- Tzaneio general hospital of Piraeus /ID# 149518 Piraeus, Attica, Greece
- General Uni hosp of Larissa /ID# 149688 Larissa, Thessaly, Greece
- General Uni hosp of Larissa /ID# 151442 Larissa, Thessaly, Greece
NCT01622348
- Conditions
- Actively Extending Plaque Psoriasis, Moderate to Severe Plaque Psoriasis, Psoriasis, +3 more
- Locations
-
- Florida Center for Dermatology, P.A Jacksonville, Florida, United States
- Atlanta Dermatology, Vein & Research Center, PC Alpharetta, Georgia, United States
- Dermatologic Surgery Specialists, Inc. Macon, Georgia, United States
- Indiana Clinical Trials Center, PC Plainfield, Indiana, United States
NCT01401452
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
Not specified
NCT01555606
- Conditions
- Moderate to Severe Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Phoenix, Arizona, United States
- Sacramento, California, United States
- Ann Arbor, Michigan, United States
- East Windsor, New Jersey, United States
NCT01644396
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- Site Reference ID/Investigator# 78433 Kazan', Russia
- Site Reference ID/Investigator# 67542 Moscow, Russia
- Site Reference ID/Investigator# 78413 Saint Petersburg, Russia
- Site Reference ID/Investigator# 67545 Saint Petersburg, Russia
NCT01202565
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- Site Reference ID/Investigator# 63776 Chotoviny, Czechia
- Site Reference ID/Investigator# 58083 Jihlava, Czechia
- Site Reference ID/Investigator# 56762 Klimkovice, Czechia
- Site Reference ID/Investigator# 56763 Klimkovice, Czechia
Completed
A Phase 2 Clinical Study of KHK4827
NCT01748539
- Conditions
- Moderate to Severe Plaque Psoriasis
- Locations
-
- For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Chiyoda-ku, Tokyo, Japan